Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioEngine
Shanghai, Shanghai, China
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Shanghai BioEngine Sci-Tech Co., Ltd. is a leading Chinese biotechnology company specializing in high-performance cell culture media and related technical services for the biopharmaceutical industry. Founded in 2014 by Professor Wen-Song Tan, the company leverages its proprietary iBioG-Med development platform to provide chemically defined and serum-free media solutions tailored for the production of monoclonal antibodies, vaccines, and cell and gene therapies (CGT). Their product portfolio includes the Eden series for CHO cells, the Celer series for 293 cells, and the HIPP series for lymphocytes, supporting more than 80 clinical projects globally. The company operates a state-of-the-art GMP-compliant manufacturing facility in Shanghai and provides 'one-stop' services including media formulation design and process optimization. BioEngine aims to provide high-quality domestic alternatives to imported media, supporting the global development and intelligent manufacturing of innovative biological drugs.
- Therapeutic areas
- OncologyRare DiseasesInfectious Diseases
- Modalities
- Monoclonal antibodyBispecific antibodyVaccineCell therapyGene therapyRecombinant proteinAntibody-drug conjugateFusion protein
- Industry
- Chemicals & Materials
02
Partnerships
ToT BiopharmWuXi AppTecEast China University of Science and Technology
Beyond the preview
Go deeper on BioEngine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioEngine.